Patrick Lang Email & Phone Number

Washington, Dc, Us

Lead development and implementation of the company’s technology strategyExecute strategy for product development and beta testing metricsHire and manage software development team to prepare for product beta testPrepare and present technology and product updates to current and potential investorsTranslate leadership's vision into clear and measurable deliverables

Hayward, California, Us

Assisted in the design and interim analysis of multiple ClinPharm studies, such as DDI, Mass Balance, and PK studiesDeveloped PopPK and PK/PD models in NONMEM using Phase I and II data to support regulatory submissions and internal decision makingConducted non-compartmental analysis in Phoenix WinNonlin and helped set up a validated system for regulatory submissionsWorked closely with other functional teams to represent ClinPharm and clearly communicate progress updates through presentationsPerformed simulations in R and NONMEM to support pediatric dose selection for multiple compounds

Lausanne, Vaud, Switzerland, Ch

Performed modeling and subsequent analysis of PK models in NONMEM and R to support regulatory submissionsAuthored Exposure Response and Population PK models for an EMA MAA submissionDeveloped automated systems for post processing and analysis of clinical dataCollaborated with an internal team to develop code templates and standard practices for the Clinical Pharmacology group Hosted ASCPT webinars to teach the pharmacometrics community about AI and its uses in pharmacometrics work

Supported communications between the Quantitative Medicine team and therapeutic area expertsPresented and delivered results to produce high quality analyses and reports for therapeutic area objectives, maximizing impact among stakeholdersDeveloped tools and GUIs to democratize model informed drug development solutionsAssisted experts with data analysis, visualization, and modeling for FDA and EMA submissions Headed research and writing for a paper comparing Machine Learning and Pharmacometric approaches to disease progression modeling in Alzheimer's DiseaseLead AI/ML efforts in webinar & training development, research in ML concepts, and communications to the pharmacometrics community

Lead data management for the Type 1 Diabetes and Transplant Therapeutics Consortia Coordinated data efforts for the regulatory qualification of islet autoantibodies by the EMA and FDADeveloped comprehensive training programs for new hires to the Data Management team Contributed to research in multiple therapeutic areas to deliver novel insights into disease progressionActed as an intermediary between Data Management team, Quantitative Medicine team, and Executive DirectorsCo-founded the AI/ML team to introduce ML concepts to the company's regulatory strategy

Collaborated with scientific leaders to create data mapping strategies for disease modelsWorked within a team to provide support to multiple scientific consortiaAided the development of new methods to receive data from scientific contributors

Bachelor Of Science In Business Administration, Mis

Pre-Business

Education record